Lundbeck
HLUN-B.CO
#2346
Rank
โ‚น548.29 B
Marketcap
โ‚น566.85
Share price
0.98%
Change (1 day)
27.21%
Change (1 year)
Lundbeck is a Danish pharmaceutical company that produces various pharmaceutical products and has the indications schizophrenia, depression, Parkinson's disease and sleep disorders.

EPS for Lundbeck (HLUN-B.CO)

EPS in 2023 (TTM): โ‚น29.01

According to Lundbeck 's latest financial reports the company's current EPS (TTM) is โ‚น29.67. In 2022 the company made an earnings per share (EPS) of โ‚น22.57 a decrease over its 2021 EPS that were of โ‚น50.68.

EPS history for Lundbeck from 2009 to 2023

Annual EPS

Year EPS Change
2023 (TTM)โ‚น29.0128.55%
2022โ‚น22.57-55.47%
2021โ‚น50.68-51.83%
2020โ‚น105.21-28.01%
2019โ‚น146.14-44.08%
2018โ‚น261.3451.94%
2017โ‚น172.00126.64%
2016โ‚น75.89-120.84%
2015-โ‚น364.175622.18%
2014-โ‚น6.36-110.03%
2013โ‚น63.43-28.08%
2012โ‚น88.19-52.1%
2011โ‚น184.11-1.31%
2010โ‚น186.5615.61%
2009โ‚น161.37